RARA CRAFT DATABASE for FDA Medical Devices
510(k)K213396

FDA DEVICE FACTS

SPIFE A1AT kit

Helena Laboratories, Corp.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 13, 2022PRODUCT CODEOBZ

Indications for use

The SPIFE A1AT kit is designed for the qualitative detection and identification of the different phenotypes of Alpha-I Antitrypsin (Al AT). Phenotyping results in conjunction with clinical findings and other laboratory assays aid in the diagnosis ofAlpha-1 Antitrypsin deficiency. The analysis is performed on human sera separated into electrophoretic patterns ready for qualitative analysis. The procedure includes isoelectrofocusing on agarose gel, performed on the semi-automatic SPIFE Touch system followed by immunofixation with anti-Alpha-I Antitrypsin antiserum. For in vitro diagnostic use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026